Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: People with dementia living in care homes often experience clinically significant agitation; however, little is known about its economic impact. OBJECTIVE: To calculate the cost of agitation in people with dementia living in care homes. METHODS: We used the baseline data from 1,424 residents with dementia living in care homes (part of Managing Agitation and Raising QUality of lifE in dementia (MARQUE) study) that had Cohen-Mansfield Agitation Inventory (CMAI) scores recorded. We investigated the relationship between residents' health and social care costs and severity of agitation based on the CMAI total score. In addition, we assessed resource utilisation and compared costs of residents with and without clinically significant symptoms of agitation using the CMAI over and above the cost of the care home. RESULTS: Agitation defined by the CMAI was a significant predictor of costs. On average, a one-point increase in the CMAI will lead to a 0.5 percentage points (cost ratio 1.005, 95%CI 1.001 to 1.010) increase in the annual costs. The excess annual cost associated with agitation per resident with dementia was £1,125.35. This suggests that, on average, agitation accounts for 44% of the annual health and social care costs of dementia in people living in care homes. CONCLUSION: Agitation in people with dementia living in care homes contributes significantly to the overall costs increasing as the level of agitation increases. Residents with the highest level of agitation cost nearly twice as much as those with the lowest levels of agitation, suggesting that effective strategies to reduce agitation are likely to be cost-effective in this setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Specific initiatives have led to a decrease in antipsychotic prescriptions for people with dementia, although often replaced with other psychotropics (figure 8 ), such as benzodiazepines, antidepressants, and mood stabilisers.211”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [211]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568 · cited 1×
“The Neuropsychiatric Inventory (NPI) assesses dementia-related behavioural symptoms examining 12 domains of behavioural functioning including agitation [20, 21].”
BackgroundLyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049 · cited 1×
“A score of�4 in any domain is usually regarded as clinically significant [22] A summed score (total NPI score) can also be calculated for total neuropsychiatric symptoms.”
BackgroundThe Neuropsychiatric Inventory: Assessing psychopathology in dementia patients
Cummings, J. L. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_6.10s · Cited by 2,017 · cited 1×
“The Neuropsychiatric Inventory (NPI) assesses dementia-related behavioural symptoms examining 12 domains of behavioural functioning including agitation [20, 21].”
BackgroundBehavioral and psychological symptoms of dementia
Cerejeira, J., Lagarto, L., & Mukaetova-Ladinska, E. B. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00073 · Cited by 1,425
A Description of Agitation in a Nursing Home
Cohen-mansfield, J., Marx, M. S., & Rosenthal, A. S. (1989) · Journal of Gerontology · doi:10.1093/geronj/44.3.m77 · Cited by 1,349 · cited 1×
“A total score of>45 is usually regarded as clinically significant agitation [19].”
BackgroundAgitated Behaviors in the Elderly: I. A Conceptual Review
Cohen‐Mansfield, J., & Billig, N. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04302.x · Cited by 717 · cited 1×
“Symptoms of agitation comprise restlessness, pacing, shouting and verbal and physical aggression [5].”
BackgroundCosting psychiatric interventions.
Beecham, J. K., & Knapp, M. R. J. (1992) · Kent Academic Repository (University of Kent) · Cited by 710
Kales, H. C., Gitlin, L. N., Lyketsos, C. G., & Dementia, T. D. E. P. O. T. A. A. M. O. T. N. S. O. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12730 · Cited by 575 · cited 2×
“Dementia is characterised by progressive cognitive disability, a high prevalence of neuropsychiatric symptoms such as agitation, depression and psychosis, reduced quality of life, increased caregiver burden and costs of care [3, 4].”
Background
Research works printed but not linked: 2
- Joint Formulary Committee British National Formulary (online) London: BMJ Group and Pharmaceutical Press. Available: https://www.bnf.org/products/bnf-online
- National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal. 2013. Available: https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781. 27905712
Cited by
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
Self-citationRetractedThe Costs of Dementia in Europe: An Updated Review and Meta-analysis
Jönsson, L., Tate, A., Frisell, O., & Wimo, A. B. (2022) · PharmacoEconomics · doi:10.1007/s40273-022-01212-z · Cited by 110
Sano, M., Cummings, J., Auer, S., Bergh, S., Fischer, C. E., Gerritsen, D., Grossberg, G., Ismail, Z., Lanctôt, K., Lapid, M. I., et al. (2024) · International Psychogeriatrics · doi:10.1017/s1041610222001041 · Cited by 91
“Amyloid positron emission tomography (PET) is increasingly used to demonstrate which older individuals with normal cognition, MCI, and dementia have excessive brain amyloid and are within the AD continuum.”
BackgroundInfluentialBurley, C. V., Livingston, G., Knapp, M. R. J., Wimo, A. B., Norman, R., & Brodaty, H. (2020) · International Psychogeriatrics · doi:10.1017/s104161022000037x · Cited by 41
“Panca, M. et al. (2019). Healthcare resource utilisation and”
BackgroundSelf-citationJames, I. A., Reichelt, K., Shirley, L. J., & Moniz-Cook, E. D. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s399697 · Cited by 27
“Studies calculate the financial impact as 44% of the total health and social care annual costs for people with dementia in care homes in the UK, and 29% of the total costs for those living at home.(17,18) The costs associated with agitation across Europe and in the US are also high, with the total incremental cost rep…”
BackgroundEscitalopram for agitation in Alzheimer’s dementia: a randomized controlled phase 3 trial
Rajji, T. K., Baksh, S. N., Shade, D. M., Ismail, Z., Burhan, A. M., Okhravi, H. R., Padala, P. R., Rosenberg, P. B., Schneider, L. S. S., Porsteinsson, A. P., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03569-y · Cited by 24
Zhu, Y., Song, T., Zhang, Z., Deng, C., Alkhalaf, M., Li, W., Yin, M., Chang, H. C. (., & Yu, P. (2022) · Journal of Gerontological Nursing · doi:10.3928/00989134-20220309-01 · Cited by 18
Salihu, D., Wong, E. M. L., Bello, U. M., & Kwan, R. Y. C. (2021) · Geriatric Nursing · doi:10.1016/j.gerinurse.2021.08.015 · Cited by 17
Sano, M. C., Zhu, C. W., Neugroschl, J. A., Grossman, H. T., Schimming, C., & Aloysi, A. S. (2022) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2022.03.008 · Cited by 14
Liu, K. Y., Borissova, A., Mahmood, J., Elliott, T., Knowles, M., Bentham, P., Reeves, S., & Howard, R. J. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12157 · Cited by 14
Marston, L., Livingston, G., Laybourne, A. H., & Cooper, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191195 · Cited by 13
“These symptoms are associated with an annual excess cost per person with dementia in care homes of £ 1,125 [4].”
Self-citationBanerjee, S., Farina, N., Henderson, C., High, J., Stirling, S., Shepstone, L., Fountain, J., Ballard, C. G., Bentham, P., Burns, A. S., et al. (2023) · Health Technology Assessment · doi:10.3310/vpdt7105 · Cited by 12
Self-citationMachine Learning to Detect Motor Agitation in People With Dementia Using Real-Time Location Data
Hasan, Z., Shum, L. C., Faruk, T., McGilton, K. S., Chu, C. H., McArthur, C., Flint, A. J., Mihailidis, A., Khan, S. S., & Iaboni, A. (2025) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2025.06.001 · Cited by 9
Cooper, C., Zabihi, S., Akhtar, A., Lee, T. C., Isaaq, A., Novere, M. L., Barber, J., Lord, K., Rapaport, P., Banks, S., et al. (2024) · Age and Ageing · doi:10.1093/ageing/afae074 · Cited by 11
“Shorter measures such as the EQ-5D may be sufficient for calculating Quality-adjusted life years (QALYs) and have better completion rates, and without the additional burden or consent processes, more clients may complete this [31].”
Self-citationMcCartney, A., Crosswell, J., Rafnsson, S. B., & Hoe, J. (2024) · Aging & Mental Health · doi:10.1080/13607863.2024.2345129 · Cited by 8
“In addition, the estimated mean excess cost associated with agitation for people with Alzheimer’s disease in the UK equates to £2billion a year (Morris et al., 2015) and agitation accounts for 44% of the annual health care costs of dementia for people living in care homes (Panca et al., 2019).”
Cesana, B. M., Poptsi, E., Tsolaki, M., Bergh, S., Ciccone, A., Cognat, E., Fabbo, A., Fascendini, S., Frisoni, G. B., Frölich, L., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13071025 · Cited by 6
“Agitation can be found in any stage of the course of dementia, from very mild to mild, and from moderate to severe, either in patients living at nursing homes [6,7] or in community-dwelling patients [8] and it is usually associated with increased healthcare costs [6].”
BackgroundTelomerase Depletion Accelerates Ageing of the Zebrafish Brain
Martins, R. R., Besse, S., Ellis, P. S., Sevil, R., Hartopp, N., Purse, C., Everett‐Brown, G., Evans, O., Mughal, N., Wahib, M. H. F., et al. (2025) · Aging Cell · doi:10.1111/acel.70280 · Cited by 5
Henderson, C., Knapp, M. R. J., Stirling, S., Shepstone, L., High, J., Ballard, C. G., Bentham, P., Burns, A. S., Farina, N., Fox, C., et al. (2022) · International Psychogeriatrics · doi:10.1017/s1041610222000436 · Cited by 4
Self-citationGombault-Datzenko, E., Costa, N., Mounié, M., Tavassoli, N., Mathieu, C., Roussel, H., Lagarrigue, J. M., Bérard, E., Rolland, Y., & Molinier, L. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04946-x · Cited by 5
Birchall, O., Bennett, M., Lawson, N., Cotton, S., & Vogel, A. P. (2019) · JBI Evidence Synthesis · doi:10.11124/jbisrir-d-19-00015 · Cited by 4
“More than 50% of adults living in RCFs experience dementia,(58) with approximately half of these adults exhibiting symptomatic agitation.(59,60) Severe agitation and a lack of cooperation could prove potentially hazardous during FEES.”
BackgroundPrimary care service utilisation pattern in dementia: a 10-year longitudinal population-based study
Tjin, A., Thang, L. L., & Stewart, R. J. (2026) · Age and Ageing · doi:10.1093/ageing/afag016 · Cited by 3
Rashid, N., Wetmore, J. B., Irfan, M., & Abler, V. (2022) · Geriatrics · doi:10.3390/geriatrics7020029 · Cited by 2
“Our findings are consistent with existing reports of increased costs associated with a dementia diagnosis and with the presence or worsening of NPS in patients with dementia [1,4,5,12,17].”
BackgroundResultInfluentialToward international consensus on the definition of agitation in cognitive disorders
Leo, D. D., & Zammarrelli, J. (2023) · International Psychogeriatrics · doi:10.1017/s1041610223000212 · Cited by 1
“Agitation is a common condition in many cognitive disorders, including Alzheimer ’ s disease, Parkinson ’ s disease, various types of dementia, and mild cognitive impairment (Panca et al ., 2019; Van der Mussele et al ., 2015).”
BackgroundDementia as a contemporary challenge for providing care for the aging populations
Klich‐Rączka, A. (2019) · Zdrowie Publiczne i Zarządzanie · doi:10.4467/20842627oz.19.003.11299
Abordaje de la agitación en el anciano con demencia
Cruz-Orduña, I., Puente-Andúes, L., Tardío, M., Rivera, B., Bullido, Y. F., & Olazarán, J. (2021) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2021.02.009
Taslim, N. A., Rampengan, D. D. C. H., Willyanto, S. E., Puling, I. M. D. R., Kumalawati, D. A., Syamsuddin, S., Lele, J. A. J. M. N., Pertiwi, J. M., Subagya, J. C., Permatasari, H. K., et al. (2024) · F1000Research · doi:10.12688/f1000research.144949.1
Kenny, K., Odell‐Miller, H., & Hsu, M. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.04.018 · Cited by 1
Gombault-Datzenko, E., Costa, N., Mounié, M., Tavassoli, N., Mathieu, C., Roussel, H., Lagarrigue, J. M., Berard, E., Rolland, Y., & Molinier, L. (2024) · Figshare · doi:10.6084/m9.figshare.26709083
Mellanen, A. (2025) · Taju (University of the Arts Helsinki) · Cited by 1
Patterns of Daily Administration of Psychoactive Drug Classes for Distress Behavior in Dementia
Boockvar, K. S., Huan, T., Curyto, K. J., Lee, S. J., & Intrator, O. K. (2026) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2026.106188
Organisational learning in dementia practice
Bartle, C. (2026) · Stirling Online Research Repository (University of Stirling)
Metadata
- Authors
- Panca, M., Livingston, G., Barber, J., Cooper, C., La Frenais, F., Marston, L., Cousins, S., & Hunter, R. M.
- Affiliations
- University College London (GB)
- Corresponding author
- Panca, Monica
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-02-26
- Volume
- 14
- Issue
- 2
- Pages
- e0211953
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6391021
- OpenAlex
- W2917337344
- Cited by
- 29
- References
- 32
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 2
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- Funders
- Economic and Social Research Council and the National Institute of Health Research (NHIR/ESCRS ES/L001780/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- dementia, agitation, care homes, health care costs, health care utilization, Cohen-Mansfield Agitation Inventory, health and social care costs, economic burden
- MeSH terms
- Aged, Aged, 80 and over, Cross-Sectional Studies, Dementia, England, Female, Homes for the Aged, Humans, Male, Middle Aged, Nursing Homes, Patient Acceptance of Health Care, Psychomotor Agitation, Quality of Life, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.